Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate

For patients with persistent or invasive gestational trophoblastic disease (GTD), systemic injection of chemotherapy is the treatment of choice if fertility is to be preserved. To prevent serious adverse effects after systemic use and possibly achieve better effects, direct local injection of chemotherapy into the tumor site, especially when in the myometrium, seems a reasonable alternative. A patient with a persistent molar pregnancy with myometrial invasion is presented. A plateau of beta-hCG (human chorionic gonadotropin) level around 550 mIU/mL was noticed for three weeks though systemic methotrexate (MTX) injection and repeat suction curettage had been performed. During the same period, a well-defined invasive complex with multiple vesicles in the myometrium was documented using transvaginal ultrasound (TVUS). Sonar-guided injection to the tumor using 50 mg MTX was performed uneventfully. An obvious shrinkage of the mass and declining beta-hCG level were demonstrated after the procedure. The patient restored her menses after the operation and a fertility evaluation including serial beta-hCG levels and hysterosalpingography showed them to be within the reference ranges. The successful outcome of this case encouraged us to treat localized invasive GTD using direct injection of MTX with the guidance of TVUS. Since no identical cases were found in our review of the English literature, more cases and similar regimens are needed to establish the safety and efficacy of this procedure.

Gestational trophoblastic disease; Ultrasound-guided injection

[1] Wang P. H., Yuan C. C., Tseng J. Y., Chao H. T.: "High-risk gestational trophoblastic disease: analysis of clinical prognoses". Eur. J. Gynaecol. Oncol., 1998, 19, 302.

[2] Jauniaux E.: "Partial moles: from postnatal to prenatal d1agnosis". Placenra, 1999, 20, 379.

[3] Wang P. H., Yuan C. C., Chao H. T., Wang H. M.:'The YIP regimen effective treatment to refractory choriocarcinoma: A case report". Chin. Med. J. (Taipei), 1997, 59, 320.

[4] Newland E. S., Paradinas F. J., Fisher R. A.: "Recent advances ,in gestational trophoblastic dissease". Hematol. Oncol. Clin. Norrh Am., 1999, 13, 225.

[5] Lazarus E., Hulka C., Siewert B., and Levine D.: "Sonographic appearance of early complete molar pregnancies". J. Ultrasound Med., 1999, 18, 589, quiz 595.

[6] Kohorn E. I., McCarthy S. M., Taylor K. J.: "Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging". J. Reprod. Med., 1998, 43, 14.

[7] Mungan T.: "Screening of persistent trophoblastic disease with various serum markers". Eur. J. Gynaecol. Oncol., 1998, 19, 495.

[8] Jauniaux E., Bersinger N. A., Gulbis B., Meuris S.: "The contribution of maternal serum markers in the early prenatal diagnosis of molar pregnancies". Hum. Reprod., 1999, 14, 842.

[9] Bidzinski M., Lemieszczuk B., Drabik M.: "The assessment of value of transvaginal ultrasound for monitoring of gestational trophoblastic disease treatment". Eu,: J. Gynaecol. Oncol., 1997, 18, 541.

[10] Manb山G., Spangnolo D., Yalsecchi L., et al.: "Transvaginal ultrasonography in persistent trophoblastic tumor". Am. J. Ohstel Gynecol., 1993, 169, 1218.

[11] Yuan C.C., Wang P.H., Ng H.T.: "High hCG level is a risk factor for predicting the occurrence of brain and/or liver metastases from gestational choriocarcinoma". Int. J. Gynecol. Ohstet., 1999, 65, 67.

[12] Berkowitz R. S., Birnholz J., Goldstein D. P. et al.: "Pelvic ultrasonography and the management of gestational trophoblastic disease". Gynecol. Oncol., 1983, 15, 403.

[13] Carter J., Carlson J., Hartenbach E. et al.: "Persistent postmolar gestational trophoblastic disease: Use of transvaginal sonography and colour flow Doppler". Aust. N.Z. J. Obstet. Gynaecol., 1993, 33, 417.

[14] Long M. G., Boultbee J.E., Langley R. et al.: "Ultrasonic morphology of the uterus and ovaries after treatment of invasive mole and gestational choriocarcinoma". Br. J. Radiol., I 990, 63, 942.

[15] Long M. G., Boultbee J.E., Langley R. et al.: "Doppler assessment of the uterine circulation and the clinical behavior of gestational trophoblastic tumors requiring chemotherapy". Br. J. Cancer, 1992, 66, 883.

[16] Santos-Ramos R., Forney J.P., Schwarz B.E.: "Sonographic findings and clinical correlations in molar pregnancy". Obstet. Gynecol., 1980, 56, 186.

[17] Schneider D.F., Bukovsky I., Weinraub Z. et al: "Transvaginal ultrasound diagnosis and treatment follow-up of invasive gestational trophoblastic disease". J. Clin. Ultrasound., 1990, 18, 110.

[18] Akira S., Ishihara T., Yamanaka A. et al.: "Laparoscopy with ultrasonographic guidance of intra-amniotic methotrexate injection for ectopic pregnancy". J. Reprod. Med., 2000, 45, 844.